Skip to main content
Top
Published in: Critical Care 5/2005

01-10-2005 | Commentary

Recently published papers: What not to do and how not to do it?

Author: Jonathan Ball

Published in: Critical Care | Issue 5/2005

Login to get access

Abstract

Controversies abound in the areas of blood transfusion, albumin, lipoproteins in sepsis and pulmonary artery catheters. We are also making too many errors, but at least there is a new nitric oxide therapy in the offing.
Literature
1.
go back to reference Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group [see comments]. N Engl J Med 1999, 340: 409-417. 10.1056/NEJM199902113400601CrossRefPubMed Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group [see comments]. N Engl J Med 1999, 340: 409-417. 10.1056/NEJM199902113400601CrossRefPubMed
2.
go back to reference Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, the Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307CrossRefPubMed Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, the Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307CrossRefPubMed
3.
go back to reference Habib RH, Zacharias A, Schwann TA, Riordan CJ, Engoren M, Durham SJ, Shah A: Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome. Crit Care Med 2005, 33: 1749-1756. 10.1097/01.CCM.0000171531.06133.B0CrossRefPubMed Habib RH, Zacharias A, Schwann TA, Riordan CJ, Engoren M, Durham SJ, Shah A: Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome. Crit Care Med 2005, 33: 1749-1756. 10.1097/01.CCM.0000171531.06133.B0CrossRefPubMed
4.
go back to reference Spiess BD: Choose one: damned if you do/damned if you don't! Crit Care Med 2005, 33: 1871-1874. 10.1097/01.CCM.0000174499.98087.40CrossRefPubMed Spiess BD: Choose one: damned if you do/damned if you don't! Crit Care Med 2005, 33: 1871-1874. 10.1097/01.CCM.0000174499.98087.40CrossRefPubMed
5.
go back to reference Young MA, Riddez L, Kjellstrom BT, Bursell J, Winslow F, Lohman J, Winslow RM: MalPEG-hemoglobin (MP4) improves hemodynamics, acid-base status, and survival after uncontrolled hemorrhage in anesthetized swine. Crit Care Med 2005, 33: 1794-1804. 10.1097/01.CCM.0000172648.55309.13CrossRefPubMed Young MA, Riddez L, Kjellstrom BT, Bursell J, Winslow F, Lohman J, Winslow RM: MalPEG-hemoglobin (MP4) improves hemodynamics, acid-base status, and survival after uncontrolled hemorrhage in anesthetized swine. Crit Care Med 2005, 33: 1794-1804. 10.1097/01.CCM.0000172648.55309.13CrossRefPubMed
6.
go back to reference Tsai AG, Cabrales P, Intaglietta M: Blood viscosity: a factor in tissue survival? Crit Care Med 2005, 33: 1662-1663. 10.1097/01.CCM.0000170177.64555.DBCrossRefPubMed Tsai AG, Cabrales P, Intaglietta M: Blood viscosity: a factor in tissue survival? Crit Care Med 2005, 33: 1662-1663. 10.1097/01.CCM.0000170177.64555.DBCrossRefPubMed
7.
go back to reference Iscoe S, Fisher JA: Hyperoxia-induced hypocapnia: an under-appreciated risk. Chest 2005, 128: 430-433. 10.1378/chest.128.1.430CrossRefPubMed Iscoe S, Fisher JA: Hyperoxia-induced hypocapnia: an under-appreciated risk. Chest 2005, 128: 430-433. 10.1378/chest.128.1.430CrossRefPubMed
8.
go back to reference Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350: 2247-2256. 10.1056/NEJMoa040232CrossRefPubMed Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350: 2247-2256. 10.1056/NEJMoa040232CrossRefPubMed
9.
go back to reference Cochrane Injuries Group Albumin Reviewers: Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998, 317: 235-240.CrossRef Cochrane Injuries Group Albumin Reviewers: Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998, 317: 235-240.CrossRef
10.
go back to reference Wilkes MM, Navickis RJ: Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001, 135: 149-164.CrossRefPubMed Wilkes MM, Navickis RJ: Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001, 135: 149-164.CrossRefPubMed
11.
go back to reference Haynes GR, Navickis RJ, Wilkes MM: Albumin administration: what is the evidence of clinical benefit? A systematic review of randomized controlled trials. Eur J Anaesthesiol 2003, 20: 771-793. 10.1017/S0265021503001273CrossRefPubMed Haynes GR, Navickis RJ, Wilkes MM: Albumin administration: what is the evidence of clinical benefit? A systematic review of randomized controlled trials. Eur J Anaesthesiol 2003, 20: 771-793. 10.1017/S0265021503001273CrossRefPubMed
12.
go back to reference Vincent JL, Navickis RJ, Wilkes MM: Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 2004, 32: 2029-2038. 10.1097/01.CCM.0000142574.00425.E9CrossRefPubMed Vincent JL, Navickis RJ, Wilkes MM: Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 2004, 32: 2029-2038. 10.1097/01.CCM.0000142574.00425.E9CrossRefPubMed
13.
go back to reference Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR: A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005, 33: 1681-1687. 10.1097/01.CCM.0000171539.47006.02CrossRefPubMed Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR: A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005, 33: 1681-1687. 10.1097/01.CCM.0000171539.47006.02CrossRefPubMed
14.
go back to reference Mangialardi RJ, Martin GS, Bernard GR, Wheeler AP, Christman BW, Dupont WD, Higgins SB, Swindell BB: Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med 2000, 28: 3137-3145. 10.1097/00003246-200009000-00001CrossRefPubMed Mangialardi RJ, Martin GS, Bernard GR, Wheeler AP, Christman BW, Dupont WD, Higgins SB, Swindell BB: Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med 2000, 28: 3137-3145. 10.1097/00003246-200009000-00001CrossRefPubMed
15.
go back to reference Martin GS, Mangialardi RJ, Wheeler AP, Dupont WD, Morris JA, Bernard GR: Albumin and furosemide therapy in hypopro-teinemic patients with acute lung injury. Crit Care Med 2002, 30: 2175-2182. 10.1097/00003246-200210000-00001CrossRefPubMed Martin GS, Mangialardi RJ, Wheeler AP, Dupont WD, Morris JA, Bernard GR: Albumin and furosemide therapy in hypopro-teinemic patients with acute lung injury. Crit Care Med 2002, 30: 2175-2182. 10.1097/00003246-200210000-00001CrossRefPubMed
16.
go back to reference Stapleton RD, Steinberg KP: Fluid balance in acute lung injury: a model of clinical trial development. Crit Care Med 2005, 33: 1857-1858. 10.1097/01.CCM.0000174480.58296.94CrossRefPubMed Stapleton RD, Steinberg KP: Fluid balance in acute lung injury: a model of clinical trial development. Crit Care Med 2005, 33: 1857-1858. 10.1097/01.CCM.0000174480.58296.94CrossRefPubMed
17.
go back to reference Bar-Or D, Bar-Or R, Rael LT, Gardner DK, Slone DS, Craun ML: Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med 2005, 33: 1638-1641. 10.1097/01.CCM.0000169876.14858.91CrossRefPubMed Bar-Or D, Bar-Or R, Rael LT, Gardner DK, Slone DS, Craun ML: Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med 2005, 33: 1638-1641. 10.1097/01.CCM.0000169876.14858.91CrossRefPubMed
18.
go back to reference Burns KE, Chu MW, Novick RJ, Fox SA, Gallo K, Martin CM, Stitt LW, Heidenheim AP, Myers ML, Moist L: Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial. JAMA 2005, 294: 342-350. 10.1001/jama.294.3.342CrossRefPubMed Burns KE, Chu MW, Novick RJ, Fox SA, Gallo K, Martin CM, Stitt LW, Heidenheim AP, Myers ML, Moist L: Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial. JAMA 2005, 294: 342-350. 10.1001/jama.294.3.342CrossRefPubMed
19.
go back to reference Tyml K, Li F, Wilson JX: Delayed ascorbate bolus protects against maldistribution of microvascular blood flow in septic rat skeletal muscle. Crit Care Med 2005, 33: 1823-1828. 10.1097/01.CCM.0000172548.34622.DECrossRefPubMed Tyml K, Li F, Wilson JX: Delayed ascorbate bolus protects against maldistribution of microvascular blood flow in septic rat skeletal muscle. Crit Care Med 2005, 33: 1823-1828. 10.1097/01.CCM.0000172548.34622.DECrossRefPubMed
20.
go back to reference Maitra SR, Shapiro MJ, Bhaduri S, El-Maghrabi MR: Effect of chemically modified tetracycline on transforming growth factor-beta1 and caspase-3 activation in liver of septic rats. Crit Care Med 2005, 33: 1577-1581. 10.1097/01.CCM.0000169880.82060.F7CrossRefPubMed Maitra SR, Shapiro MJ, Bhaduri S, El-Maghrabi MR: Effect of chemically modified tetracycline on transforming growth factor-beta1 and caspase-3 activation in liver of septic rats. Crit Care Med 2005, 33: 1577-1581. 10.1097/01.CCM.0000169880.82060.F7CrossRefPubMed
21.
go back to reference Vermont CL, den Brinker M, Kakeci N, de Kleijn ED, de Rijke YB, Joosten KF, de Groot R, Hazelzet JA: Serum lipids and disease severity in children with severe meningococcal sepsis. Crit Care Med 2005, 33: 1610-1615. 10.1097/01.CCM.0000171272.50888.ADCrossRefPubMed Vermont CL, den Brinker M, Kakeci N, de Kleijn ED, de Rijke YB, Joosten KF, de Groot R, Hazelzet JA: Serum lipids and disease severity in children with severe meningococcal sepsis. Crit Care Med 2005, 33: 1610-1615. 10.1097/01.CCM.0000171272.50888.ADCrossRefPubMed
22.
go back to reference Chien JY, Jerng JS, Yu CJ, Yang PC: Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 2005, 33: 1688-1693. 10.1097/01.CCM.0000171183.79525.6BCrossRefPubMed Chien JY, Jerng JS, Yu CJ, Yang PC: Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 2005, 33: 1688-1693. 10.1097/01.CCM.0000171183.79525.6BCrossRefPubMed
23.
go back to reference Germann P, Braschi A, Della Rocca G, Dinh-Xuan AT, Falke K, Frostell C, Gustafsson LE, Herve P, Jolliet P, Kaisers U, et al.: Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med 2005, 31: 1029-1041. 10.1007/s00134-005-2675-4CrossRefPubMed Germann P, Braschi A, Della Rocca G, Dinh-Xuan AT, Falke K, Frostell C, Gustafsson LE, Herve P, Jolliet P, Kaisers U, et al.: Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med 2005, 31: 1029-1041. 10.1007/s00134-005-2675-4CrossRefPubMed
24.
go back to reference Shiva S, Gladwin MT: Nitrite therapeutics: back to the future. Crit Care Med 2005, 33: 1865-1867. 10.1097/01.CCM.0000178368.45394.42CrossRefPubMed Shiva S, Gladwin MT: Nitrite therapeutics: back to the future. Crit Care Med 2005, 33: 1865-1867. 10.1097/01.CCM.0000178368.45394.42CrossRefPubMed
25.
go back to reference Bjorne H, Govoni M, Tornberg DC, Lundberg JO, Weitzberg E: Intragastric nitric oxide is abolished in intubated patients and restored by nitrite. Crit Care Med 2005, 33: 1722-1727. 10.1097/01.CCM.0000171204.59502.AACrossRefPubMed Bjorne H, Govoni M, Tornberg DC, Lundberg JO, Weitzberg E: Intragastric nitric oxide is abolished in intubated patients and restored by nitrite. Crit Care Med 2005, 33: 1722-1727. 10.1097/01.CCM.0000171204.59502.AACrossRefPubMed
26.
go back to reference Rothschild JM, Landrigan CP, Cronin JW, Kaushal R, Lockley SW, Burdick E, Stone PH, Lilly CM, Katz JT, Czeisler CA, et al.: The Critical Care Safety Study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 2005, 33: 1694-1700. 10.1097/01.CCM.0000171609.91035.BDCrossRefPubMed Rothschild JM, Landrigan CP, Cronin JW, Kaushal R, Lockley SW, Burdick E, Stone PH, Lilly CM, Katz JT, Czeisler CA, et al.: The Critical Care Safety Study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 2005, 33: 1694-1700. 10.1097/01.CCM.0000171609.91035.BDCrossRefPubMed
27.
go back to reference Harvey S, Harrison DA, Singer M, Ashcroft J, Jones CM, Elbourne D, Brampton W, Williams D, Young D, Rowan K: Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 2005, 366: 472-477. 10.1016/S0140-6736(05)67061-4CrossRefPubMed Harvey S, Harrison DA, Singer M, Ashcroft J, Jones CM, Elbourne D, Brampton W, Williams D, Young D, Rowan K: Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 2005, 366: 472-477. 10.1016/S0140-6736(05)67061-4CrossRefPubMed
Metadata
Title
Recently published papers: What not to do and how not to do it?
Author
Jonathan Ball
Publication date
01-10-2005
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2005
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc3812

Other articles of this Issue 5/2005

Critical Care 5/2005 Go to the issue